Loading...

CANCER MARKER PROFILE THYROID DTC

image not found

NABL Cap Accredited 
The Thyroid DTC (Differentiated Thyroid Cancer) Cancer Marker Profile at Metropolis Healthcare evaluates blood markers to detect and monitor differentiated thyroid cancers. It aids in early diagnosis, post-surgery monitoring, and assessment of treatment effectiveness. Metropolis ensures precise results using advanced immunoassay technology and expert oncological interpretation.

  • 17 Crores+ Samples Processed
  • World Class Technology Labs
  • 25+ Years of Trust & Experience
  • Free Home Collection

Price: Rs. 2,330.00

Sample Type: Serum

Fasting Not Requierd


Frequently Asked Questions (FAQ's):

What is included in the Thyroid DTC Cancer Marker Profile?
It typically measures Thyroglobulin and anti-thyroglobulin antibodies to monitor differentiated thyroid cancer and detect recurrence.

Who should consider this test?
Patients with a history of thyroid cancer, post-thyroidectomy follow-up, or those undergoing treatment for thyroid malignancy.

How is the sample collected?
A blood sample is collected at Metropolis Healthcare for tumor marker analysis.

Is fasting required for this test?
No fasting is needed. The test can be performed without special preparation.

How accurate are the results from Metropolis Healthcare?
Metropolis ensures high reliability using validated immunoassay platforms, expert technicians, and strict quality control.

Can this test diagnose thyroid cancer on its own?
No, it is a supportive tool. Diagnosis requires imaging, biopsy, and clinical evaluation.

How often should this test be done?
Frequency depends on post-surgery follow-up, treatment monitoring, or doctor’s recommendation.

How does this test help in treatment planning?
It helps track therapy response, detect recurrence early, and guide clinical decisions for managing differentiated thyroid cancer.

OUR corporates PARTNER

Feedback

Patient's Testimonials

Trusted by Thousands

OUR Accreditations

OUR Lab